These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12111199

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
    Lee I, Radosevich JA, Chejfec G, Ma YX, Warren WH, Rosen ST, Gould VE.
    Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
    [Abstract] [Full Text] [Related]

  • 5. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG.
    Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT, Gentile P, Tarectecan A, Fuchs A.
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
    Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K.
    Pathol Int; 2007 Apr; 57(4):190-9. PubMed ID: 17316414
    [Abstract] [Full Text] [Related]

  • 14. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR, Zhai J.
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [Abstract] [Full Text] [Related]

  • 15. NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas.
    Lantuéjoul S, Laverrière MH, Sturm N, Moro D, Frey G, Brambilla C, Brambilla E.
    Hum Pathol; 2000 Apr; 31(4):415-21. PubMed ID: 10821486
    [Abstract] [Full Text] [Related]

  • 16. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE, Novelli L, Boddi V, Paglierani M, Dini S.
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [Abstract] [Full Text] [Related]

  • 17. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
    Mimura T, Ito A, Sakuma T, Ohbayashi C, Yoshimura M, Tsubota N, Okita Y, Okada M.
    Cancer; 2007 Mar 01; 109(5):933-8. PubMed ID: 17279584
    [Abstract] [Full Text] [Related]

  • 18. D2-40: a reliable marker in the diagnosis of pleural mesothelioma.
    Müller AM, Franke FE, Müller KM.
    Pathobiology; 2006 Mar 01; 73(1):50-4. PubMed ID: 16785767
    [Abstract] [Full Text] [Related]

  • 19. Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.
    Amatya VJ, Takeshima Y, Kohno H, Kushitani K, Yamada T, Morimoto C, Inai K.
    Histopathology; 2009 Jul 01; 55(1):10-9. PubMed ID: 19614762
    [Abstract] [Full Text] [Related]

  • 20. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
    Ordóñez NG.
    Mod Pathol; 1998 Oct 01; 11(10):929-33. PubMed ID: 9796717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.